{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:59:44Z","timestamp":1790996384329,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006455","name":"Stiftung Forschung 3R","doi-asserted-by":"publisher","award":["OC-2020-002"],"award-info":[{"award-number":["OC-2020-002"]}],"id":[{"id":"10.13039\/501100006455","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["CRSK-3_195902"],"award-info":[{"award-number":["CRSK-3_195902"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022663","name":"M\u00e4xi Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022663","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Currently, there is no regenerative therapy for patients with neurological and neurodegenerative disorders. Cell-therapies have emerged as a potential treatment for numerous brain diseases. Despite recent advances in stem cell technology, major concerns have been raised regarding the feasibility and safety of cell therapies for clinical applications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We generated good manufacturing practice (GMP)-compatible neural progenitor cells (NPCs) from transgene- and xeno-free induced pluripotent stem cells (iPSCs) that can be smoothly adapted for clinical applications. NPCs were characterized in vitro for their differentiation potential and in vivo after transplantation into wild type as well as genetically immunosuppressed mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Generated NPCs had a stable gene-expression over at least 15 passages and could be scaled for up to 10\n                      <jats:sup>18<\/jats:sup>\n                      cells per initially seeded 10\n                      <jats:sup>6<\/jats:sup>\n                      cells. After withdrawal of growth factors in vitro, cells adapted a neural fate and mainly differentiated into active neurons. To ensure a pure NPC population for in vivo applications, we reduced the\u00a0risk of iPSC contamination by applying micro RNA-switch technology as a safety checkpoint. Using lentiviral transduction with a fluorescent and bioluminescent dual-reporter construct, combined with non-invasive in vivo bioluminescent imaging, we longitudinally tracked the grafted cells in healthy wild-type and genetically immunosuppressed mice as well as in a mouse model of ischemic stroke. Long term in-depth characterization revealed that transplanted NPCs have the capability to survive and spontaneously differentiate into functional and mature neurons throughout a time course of a month, while no residual pluripotent cells were detectable.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We describe the generation of transgene- and xeno-free NPCs. This simple differentiation protocol combined with the ability of in vivo cell tracking presents a valuable tool to develop safe and effective cell therapies for various brain injuries.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-022-03610-5","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T17:02:44Z","timestamp":1663347764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Xeno-free induced pluripotent stem cell-derived neural progenitor cells for in vivo applications"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3376-3453","authenticated-orcid":false,"given":"Ruslan","family":"Rust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6912-3573","authenticated-orcid":false,"given":"Rebecca Z.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8396-3256","authenticated-orcid":false,"given":"Melanie","family":"Generali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Kehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Bodenmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Uhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin J.","family":"Z\u00fcrcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8570-5784","authenticated-orcid":false,"given":"Hirohide","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P.","family":"Hoerstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger M.","family":"Nitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0019-3055","authenticated-orcid":false,"given":"Christian","family":"Tackenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"issue":"9","key":"3610_CR1","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.tins.2019.05.006","volume":"42","author":"R Rust","year":"2019","unstructured":"Rust R, Gr\u00f6nnert L, Weber RZ, Mulders G, Schwab ME. Refueling the Ischemic CNS: Guidance Molecules for Vascular Repair. Trends Neurosci. 2019;42(9):644\u201356.","journal-title":"Trends Neurosci"},{"issue":"1","key":"3610_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13287-017-0643-x","volume":"8","author":"A Nagpal","year":"2017","unstructured":"Nagpal A, Choy FC, Howell S, Hillier S, Chan F, Hamilton-Bruce MA, et al. Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review and meta-analysis. Stem Cell Res Ther. 2017;8(1):191.","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"3610_CR3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/sctm.19-0076","volume":"8","author":"CV Borlongan","year":"2019","unstructured":"Borlongan CV. Concise Review: Stem Cell Therapy for Stroke Patients: Are We There Yet? Stem Cells Transl Med. 2019;8(9):983\u20138.","journal-title":"Stem Cells Transl Med"},{"key":"3610_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.628663","volume":"15","author":"R Duan","year":"2021","unstructured":"Duan R, Gao Y, He R, Jing L, Li Y, Gong Z, et al. Induced Pluripotent Stem Cells for Ischemic Stroke Treatment. Front Neurosci. 2021;15: 628663.","journal-title":"Front Neurosci"},{"issue":"4","key":"3610_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","volume":"27","author":"S Yamanaka","year":"2020","unstructured":"Yamanaka S. Pluripotent Stem Cell-Based Cell Therapy-Promise and Challenges. Cell Stem Cell. 2020;27(4):523\u201331.","journal-title":"Cell Stem Cell"},{"issue":"8","key":"3610_CR6","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2183\/pjab.85.348","volume":"85","author":"N Fusaki","year":"2009","unstructured":"Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci. 2009;85(8):348\u201362.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"1","key":"3610_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13287-019-1163-7","volume":"10","author":"D Bohaciakova","year":"2019","unstructured":"Bohaciakova D, Hruska-Plochan M, Tsunemoto R, Gifford WD, Driscoll SP, Glenn TD, et al. A scalable solution for isolating human multipotent clinical-grade neural stem cells from ES precursors. Stem Cell Res Ther. 2019;10(1):83.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"3610_CR8","doi-asserted-by":"publisher","first-page":"32532","DOI":"10.1038\/srep32532","volume":"9","author":"CJ Parr","year":"2016","unstructured":"Parr CJ, Katayama S, Miki K, Kuang Y, Yoshida Y, Morizane A, et al. MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells. Sci Rep. 2016;9(6):32532.","journal-title":"Sci Rep"},{"issue":"6","key":"3610_CR9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.stem.2015.04.005","volume":"16","author":"K Miki","year":"2015","unstructured":"Miki K, Endo K, Takahashi S, Funakoshi S, Takei I, Katayama S, et al. Efficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches. Cell Stem Cell. 2015;16(6):699\u2013711.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"3610_CR10","doi-asserted-by":"publisher","first-page":"10743","DOI":"10.1038\/ncomms10743","volume":"22","author":"I Sancho-Martinez","year":"2016","unstructured":"Sancho-Martinez I, Nivet E, Xia Y, Hishida T, Aguirre A, Ocampo A, et al. Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. Nat Commun. 2016;22(7):10743.","journal-title":"Nat Commun"},{"key":"3610_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.scr.2018.01.019","volume":"27","author":"JH Birnbaum","year":"2018","unstructured":"Birnbaum JH, Wanner D, Gietl AF, Saake A, Hock C, Nitsch RM, et al. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-beta and tau pathology in iPSC-derived neurons from sporadic Alzheimer\u2019s disease patients. Stem Cell Research. 2018;27:121\u201330.","journal-title":"Stem Cell Research"},{"key":"3610_CR12","doi-asserted-by":"publisher","unstructured":"Fujita Y, Hirosawa M, Hayashi K, Hatani T, Yoshida Y, Yamamoto T, Saito H. A versatile and robust cell purification system with an RNA-only circuit composed of microRNA-responsive ON and OFF switches. Sci Adv 2022. https:\/\/doi.org\/10.1126\/sciadv.abj1793","DOI":"10.1126\/sciadv.abj1793"},{"key":"3610_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/2022.07.28.501836","author":"RZ Weber","year":"2022","unstructured":"Weber RZ, Mulders G, Perron P, Tackenberg C, Rust R. Molecular and anatomical roadmap of stroke pathology in immunodeficient mice. bioRxiv. 2022. https:\/\/doi.org\/10.1101\/2022.07.28.501836.","journal-title":"bioRxiv"},{"key":"3610_CR14","doi-asserted-by":"publisher","DOI":"10.3791\/63102","author":"RZ Weber","year":"2022","unstructured":"Weber RZ, Bodenmann C, Uhr D, Z\u00fcrcher KJ, Wanner D, Nitsch RM, et al. Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain. J Vis Exp. 2022. https:\/\/doi.org\/10.3791\/63102.","journal-title":"J Vis Exp"},{"issue":"32","key":"3610_CR15","doi-asserted-by":"publisher","first-page":"11839","DOI":"10.1073\/pnas.0404474101","volume":"101","author":"S Kelly","year":"2004","unstructured":"Kelly S, Bliss TM, Shah AK, Sun GH, Ma M, Foo WC, et al. Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci. 2004;101(32):11839\u201344.","journal-title":"Proc Natl Acad Sci"},{"key":"3610_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/10738584221110100","author":"R Rust","year":"2022","unstructured":"Rust R, Tackenberg C. Stem cell therapy for repair of the injured brain: Five principles. Neuroscientist. 2022. https:\/\/doi.org\/10.1177\/10738584221110100.","journal-title":"Neuroscientist"},{"issue":"28","key":"3610_CR17","doi-asserted-by":"publisher","first-page":"14270","DOI":"10.1073\/pnas.1905309116","volume":"116","author":"R Rust","year":"2019","unstructured":"Rust R, Gr\u00f6nnert L, Gantner C, Enzler A, Mulders G, Weber RZ, et al. Nogo-a targeted therapy promotes vascular repair and functional recovery following stroke. Proc Natl Acad Sci U S A. 2019;116(28):14270\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3610_CR18","doi-asserted-by":"publisher","first-page":"20040","DOI":"10.1038\/s41598-019-56634-1","volume":"9","author":"R Rust","year":"2019","unstructured":"Rust R, Weber RZ, Gr\u00f6nnert L, Mulders G, Maurer MA, Hofer AS, et al. Anti-Nogo-a antibodies prevent vascular leakage and act as pro-angiogenic factors following stroke. Sci Rep. 2019;9(1):20040.","journal-title":"Sci Rep"},{"key":"3610_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.586226","volume":"11","author":"RZ Weber","year":"2020","unstructured":"Weber RZ, Gr\u00f6nnert L, Mulders G, Maurer MA, Tackenberg C, Schwab ME, et al. Characterization of the blood brain barrier disruption in the photothrombotic stroke model. Front Physiol. 2020;11: 586226.","journal-title":"Front Physiol"},{"key":"3610_CR20","doi-asserted-by":"publisher","DOI":"10.1101\/2021.08.11.455647v1","author":"RZ Weber","year":"2021","unstructured":"Weber RZ, Mulders G, Kaiser J, Tackenberg C, Rust R. Deep learning based behavioral profiling of rodent stroke recovery. Biorxiv. 2021. https:\/\/doi.org\/10.1101\/2021.08.11.455647v1.","journal-title":"Biorxiv"},{"issue":"2","key":"3610_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055662","volume":"8","author":"M Aswendt","year":"2013","unstructured":"Aswendt M, Adamczak J, Couillard-Despres S, Hoehn M. Boosting bioluminescence neuroimaging: an optimized protocol for brain studies. PLoS ONE. 2013;8(2): e55662.","journal-title":"PLoS ONE"},{"key":"3610_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-1-0716-1441-9_5","volume":"2312","author":"H Nakanishi","year":"2021","unstructured":"Nakanishi H, Saito H. Purification of specific cell populations differentiated from stem cells using microRNA-responsive synthetic messenger RNAs. Methods Mol Biol. 2021;2312:73\u201386.","journal-title":"Methods Mol Biol"},{"issue":"20","key":"3610_CR23","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.1073\/pnas.1014041108","volume":"108","author":"W Li","year":"2011","unstructured":"Li W, Sun W, Zhang Y, Wei W, Ambasudhan R, Xia P, et al. Rapid induction and long-term self-renewal of primitive neural precursors from human embryonic stem cells by small molecule inhibitors. Proc Natl Acad Sci U S A. 2011;108(20):8299\u2013304.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"3610_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2183\/pjab.92.412","volume":"92","author":"P Karagiannis","year":"2016","unstructured":"Karagiannis P, Fujita Y, Saito H. RNA-based gene circuits for cell regulation. Proc Jpn Acad Ser B Phys Biol Sci. 2016;92(9):412\u201322.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"1","key":"3610_CR25","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s13287-020-01915-0","volume":"11","author":"L Vitillo","year":"2020","unstructured":"Vitillo L, Durance C, Hewitt Z, Moore H, Smith A, Vallier L. GMP-grade neural progenitor derivation and differentiation from clinical-grade human embryonic stem cells. Stem Cell Res Ther. 2020;11(1):406.","journal-title":"Stem Cell Res Ther"},{"key":"3610_CR26","volume-title":"Methods in molecular biology","author":"L Vitillo","year":"2021","unstructured":"Vitillo L, Vallier L. Derivation of Multipotent Neural Progenitors from Human Embryonic Stem Cells for Cell Therapy and Biomedical Applications. In: Turksen K, editor. Methods in molecular biology. Clifton NJ: Springer; 2021."},{"issue":"1","key":"3610_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13041-016-0265-8","volume":"9","author":"K Sugai","year":"2016","unstructured":"Sugai et al., First-in-human clinical trial of transplantation of iPSC-derived NS\/PCs in subacute complete spinal cord injury: Study protocol. 2021. Regen Ther. https:\/\/doi.org\/10.1016\/j.reth.2021.08.005.","journal-title":"Mol Brain"},{"key":"3610_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.reth.2020.06.002","volume":"13","author":"J Takahashi","year":"2020","unstructured":"Takahashi J. iPS cell-based therapy for Parkinson\u2019s disease: A Kyoto trial. Regen Ther. 2020;13:18\u201322.","journal-title":"Regen Ther"},{"issue":"1","key":"3610_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/scd.2006.0057","volume":"16","author":"X Xia","year":"2007","unstructured":"Xia X, Zhang Y, Zieth CR, Zhang SC. Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner. Stem Cells Dev. 2007;16(1):167\u201376.","journal-title":"Stem Cells Dev"},{"issue":"2","key":"3610_CR30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019;25(2):270\u20136.","journal-title":"Nat Med"},{"issue":"Pt 6","key":"3610_CR31","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/brain\/awr094","volume":"134","author":"RH Andres","year":"2011","unstructured":"Andres RH, Horie N, Slikker W, Keren-Gill H, Zhan K, Sun G, et al. Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain. 2011;134(Pt 6):1777\u201389.","journal-title":"Brain"},{"key":"3610_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.biomaterials.2016.07.028","volume":"105","author":"P Moshayedi","year":"2016","unstructured":"Moshayedi P, Nih LR, Llorente IL, Berg AR, Cinkornpumin J, Lowry WE, et al. Systematic optimization of an engineered hydrogel allows for selective control of human neural stem cell survival and differentiation after transplantation in the stroke brain. Biomaterials. 2016;105:145\u201355.","journal-title":"Biomaterials"},{"issue":"9","key":"3610_CR33","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/nm.4154","volume":"22","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhao Z, Rege SV, Wang M, Si G, Zhou Y, et al. 3K3A-activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice. Nat Med. 2016;22(9):1050\u20135.","journal-title":"Nat Med"},{"issue":"1","key":"3610_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/cr.2011.133","volume":"22","author":"M Patterson","year":"2012","unstructured":"Patterson M, Chan DN, Ha I, Case D, Cui Y, Handel BV, et al. Defining the nature of human pluripotent stem cell progeny. Cell Res. 2012;22(1):178\u201393.","journal-title":"Cell Res"},{"issue":"5","key":"3610_CR35","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.stemcr.2014.09.021","volume":"3","author":"Y Xie","year":"2014","unstructured":"Xie Y, Zhang J, Lin Y, Gaeta X, Meng X, Wisidagama DRR, et al. Defining the role of oxygen tension in human neural progenitor fate. Stem Cell Rep. 2014;3(5):743\u201357.","journal-title":"Stem Cell Rep"},{"issue":"590","key":"3610_CR36","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1126\/scitranslmed.aaz6747","volume":"13","author":"IL Llorente","year":"2021","unstructured":"Llorente IL, Xie Y, Mazzitelli JA, Hatanaka EA, Cinkornpumin J, Miller DR, et al. Patient-derived glial enriched progenitors repair functional deficits due to white matter stroke and vascular dementia in rodents. Sci Transl Med. 2021;13(590):6747.","journal-title":"Sci Transl Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03610-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03610-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03610-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T17:06:32Z","timestamp":1663347992000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03610-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3610"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03610-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.01.18.476253","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"assertion":[{"value":"3 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use of human iPSC lines was approved by the Zurich Cantonal Ethics Committee (Approval Nr.: 2014\u20130430). Animal experiments were performed in accordance with governmental and institutional (University of Zurich) guidelines and have been approved by the Cantonal Veterinary Office of Zurich (License number: 31687).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Hirohide Saito owns shares and is outside director of aceRNA Technologies, Ltd.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"421"}}